Article Versions Notes

Zhang J-F, Park J-Y, Kim S-W, Choi Y-R, Cha S-Y, Jang H-K, Wei B, Kang M. Development of a Highly Efficient CRISPR/Cas9-Mediated Herpesvirus of Turkey-Based Vaccine against Novel Variant Infectious Bursal Disease Virus. Vaccines. 2024; 12(3):226. https://doi.org/10.3390/vaccines12030226

Zhang, Jun-Feng, Jong-Yeol Park, Sang-Won Kim, Yu-Ri Choi, Se-Yeoun Cha, Hyung-Kwan Jang, Bai Wei, and Min Kang. 2024. "Development of a Highly Efficient CRISPR/Cas9-Mediated Herpesvirus of Turkey-Based Vaccine against Novel Variant Infectious Bursal Disease Virus" Vaccines 12, no. 3: 226. https://doi.org/10.3390/vaccines12030226

Zhang, J.-F., Park, J.-Y., Kim, S.-W., Choi, Y.-R., Cha, S.-Y., Jang, H.-K., Wei, B., & Kang, M. (2024). Development of a Highly Efficient CRISPR/Cas9-Mediated Herpesvirus of Turkey-Based Vaccine against Novel Variant Infectious Bursal Disease Virus. Vaccines, 12(3), 226. https://doi.org/10.3390/vaccines12030226